BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10572079)

  • 1. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
    Nowak-Göttl U; Sträter R; Heinecke A; Junker R; Koch HG; Schuierer G; von Eckardstein A
    Blood; 1999 Dec; 94(11):3678-82. PubMed ID: 10572079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.
    Nowak-Göttl U; Wermes C; Junker R; Koch HG; Schobess R; Fleischhack G; Schwabe D; Ehrenforth S
    Blood; 1999 Mar; 93(5):1595-9. PubMed ID: 10029588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.
    Günther G; Junker R; Sträter R; Schobess R; Kurnik K; Heller C; Kosch A; Nowak-Göttl U;
    Stroke; 2000 Oct; 31(10):2437-41. PubMed ID: 11022077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.
    Münchow N; Kosch A; Schobess R; Junker R; Auberger K; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S109-12. PubMed ID: 10650847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
    Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
    Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.
    Pezzini A; Del Zotto E; Magoni M; Costa A; Archetti S; Grassi M; Akkawi NM; Albertini A; Assanelli D; Vignolo LA; Padovani A
    Stroke; 2003 Jan; 34(1):28-33. PubMed ID: 12511746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.
    Kosch A; Junker R; Kurnik K; Schobess R; Günther G; Koch H; Nowak-Göttl U
    Thromb Res; 2000 Sep; 99(6):531-7. PubMed ID: 10974337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.
    Lopaciuk S; Bykowska K; Kwiecinski H; Mickielewicz A; Czlonkowska A; Mendel T; Kuczynska-Zardzewialy A; Szelagowska D; Windyga J; Schröder W; Herrmann FH; Jedrzejowska H
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):346-50. PubMed ID: 11697722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.
    von Depka M; Nowak-Göttl U; Eisert R; Dieterich C; Barthels M; Scharrer I; Ganser A; Ehrenforth S
    Blood; 2000 Nov; 96(10):3364-8. PubMed ID: 11071628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
    Nowak-Göttl U; Sträter R; Kosch A; von Eckardstein A; Schobess R; Luigs P; Nabel P; Vielhaber H; Kurnik K; Junker R
    Eur J Haematol; 2001 Jan; 66(1):57-62. PubMed ID: 11168509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey.
    Sträter R; Vielhaber H; Kassenböhmer R; von Kries R; Göbel U; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S122-5. PubMed ID: 10650850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
    Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
    Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
    Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
    Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.
    Lu Y; Zhao Y; Liu G; Wang X; Liu Z; Chen B; Hui R
    Thromb Res; 2002 Apr; 106(1):7-12. PubMed ID: 12165282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M; Arnaud E; Nicaud V; Aubry ML; Fiessinger JN; Aiach M; Emmerich J
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.